Abstract
The Editor-in-Chief of Cancer Biotherapy and Radiopharmaceuticals officially retracts the article entitled, “C Long Noncoding RNA CTD-2589M5.4 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion Via Downregulation of the Extracellular Matrix-Receptor Interaction Pathway,” by Yuanyuan Gu, Ke Huang, Min Zhang, Fang Teng, Lili Ge, Juan Zhou, Juan Xu, and Xuemei Jia (Cancer Biother Radiopharm, 37(7):2022;580–588; doi: 10.1089/cbr.2020.4429).
The corresponding author of the paper, Dr. Xuemei Jia, contacted the journal's editorial office requesting to replace Figure 3K in the published article, stating:
”An error was identified in Fig. 3K, which was made by careless figure assembling. These experiments were repeated by two students for at least three times….These corrections do not change the conclusion of this article. All authors agree to the correction and apologize for any inconvenience caused.” [sic]
An independent analysis of the figures was performed which confirmed image manipulation, raising doubts about the originality of data and the reliability of the published results.
Dr. Xuemei Jia, as well as all coauthors, were notified via email of the decision to retract, utilizing the email addresses provided to the journal at the time of submission in 2020, though no responses were received.
The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the veracity of scientific literature and the community it serves.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
